Effects of Risperidone and Galantamine Treatment on Alzheimer’s Disease Biomarker Levels in Cerebrospinal Fluid
2017 ◽
Vol 57
(2)
◽
pp. 387-393
◽
Keyword(s):
2013 ◽
Vol 930
◽
pp. 129-135
◽
Keyword(s):
2017 ◽
Vol 10
(1)
◽
pp. 94-98
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 26
(2)
◽
pp. 255-262
◽
Keyword(s):
2018 ◽
Vol 14
(4)
◽
pp. 492-501
◽
Keyword(s):